Aptah BioSciences
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
930 Brittan Ave # 307, San Carlos, Calif...Website
www.aptah-bio.comRevenue
<$5 MillionIndustry
About Aptah BioSciences
Aptah Biosciences specializes in RNA rejuvenation technology aimed at restoring RNA function to combat age-related diseases and various medical conditions, including cancer and neurodegenerative diseases. Their lead compound, APT20TTMG, targets U1-snRNP to enhance gene expression by preventing premature transcription termination. The company focuses on addressing unmet medical needs through innovative solutions that modulate RNA processing without affecting healthy cells. Aptah's technology holds promise for a wide range of sporadic genetic disorders, offering hope for improved health outcomes.Explore more
Aptah BioSciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Aptah BioSciences
Compare insights from companies similar to Aptah BioSciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aptah BioSciences Tech Stack
A closer look at the technologies used by Aptah BioSciences
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aptah BioSciences
Sign Up For FreeTo access detailed company insights
Aptah Biosciences specializes in RNA rejuvenation technology aimed at restoring RNA function to combat age-related diseases and various medical conditions, including cancer and neurodegenerative diseases. Their lead compound, APT20TTMG, targets U1-snRNP to enhance gene expression by preventing premature transcription termination. The company focuse... Read More
